US$ 20.69
noom glp-1 rx Why We Launched GLP-1RX Noom shifts GLP-1 strategy toward
Description
Get help with your weight management goals

Most people think the obesity drug race is @EliLillyandCo versus @novonordisk Half of it is now in China

In recent years, glucagon-like peptide 1 receptor agonists (GLP-1RAs) have become central in the treatment of type 2 diabetes (T2D)

Many of these disorders, including obesity and auto-immune diseases, have been associated with decreased gut barrier function and consequent increased inflammation

GLP-1 receptor agonists like semaglutide and tirzepatide may influence immune function during flu season
